133 related articles for article (PubMed ID: 5014316)
1. Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro.
Tsuchiya T; Levy G
J Pharm Sci; 1972 Apr; 61(4):586-9. PubMed ID: 5014316
[No Abstract] [Full Text] [Related]
2. Drug adsorption efficacy of commercial activated charcoal tablets in vitro and in man.
Tsuchiya T; Levy G
J Pharm Sci; 1972 Apr; 61(4):624-5. PubMed ID: 4552282
[No Abstract] [Full Text] [Related]
3. Effect of activated charcoal on aspirin absorption in man. Part I.
Levy G; Tsuchiya T
Clin Pharmacol Ther; 1972; 13(3):317-22. PubMed ID: 5026372
[No Abstract] [Full Text] [Related]
4. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.
Neuvonen PJ; Elfving SM; Elonen E
Eur J Clin Pharmacol; 1978 May; 13(3):213-8. PubMed ID: 668776
[TBL] [Abstract][Full Text] [Related]
5. Displacement of brain and heart noradrenaline by p-hydroxynorephedrine after administration of p-hydroxyamphetamine.
Lewander T
Acta Pharmacol Toxicol (Copenh); 1971; 29(1):20-32. PubMed ID: 5107804
[No Abstract] [Full Text] [Related]
6. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
Levy G; Soda DM; Lampman TA
Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
[TBL] [Abstract][Full Text] [Related]
7. Absorption studies with ritodrine an adrenergic beta stimulant drug.
Marmo E; Vacca C; Saini RK; Fici F
Boll Chim Farm; 1974 Oct; 113(10):559-61. PubMed ID: 4447682
[No Abstract] [Full Text] [Related]
8. Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man.
Neuvonen PJ; Olkkola KT; Alanen T
Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):1-7. PubMed ID: 6702463
[TBL] [Abstract][Full Text] [Related]
9. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
[TBL] [Abstract][Full Text] [Related]
10. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
Juhl RP
Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of aspirin absorption by activated charcoal and apomorphine.
Decker WJ; Shpall RA; Corby DG; Combs HF; Payne CE
Clin Pharmacol Ther; 1969; 10(5):710-3. PubMed ID: 5808464
[No Abstract] [Full Text] [Related]
12. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
Scholtz EC; Jaffe JM; Colaizzi JL
Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
[No Abstract] [Full Text] [Related]
13. Effect of purgatives on antidotal efficacy of oral activated charcoal.
Neuvonen PJ; Olkkola KT
Hum Toxicol; 1986 Jul; 5(4):255-63. PubMed ID: 3733116
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
Easom JM; Caraccio TR; Lovejoy FH
Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the intestinal absorption of sympathomimetics in man].
Petry R; Kolb KH
Arzneimittelforschung; 1973 Nov; 23(11):1535-8. PubMed ID: 4801658
[No Abstract] [Full Text] [Related]
16. Effect of delayed administration of activated charcoal on nortriptyline absorption.
Dawling S; Crome P; Braithwaite R
Eur J Clin Pharmacol; 1978 Dec; 14(6):445-7. PubMed ID: 738352
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of oral activated charcoal in acute intoxications.
Neuvonen PJ
Clin Pharmacokinet; 1982; 7(6):465-89. PubMed ID: 6761032
[No Abstract] [Full Text] [Related]
18. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose.
Mayersohn M; Perrier D; Picchioni AL
Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318
[TBL] [Abstract][Full Text] [Related]
19. Effect of activated charcoal on absorption of tolbutamide and valproate in man.
Neuvonen PJ; Kannisto H; Hirvisalo EL
Eur J Clin Pharmacol; 1983; 24(2):243-6. PubMed ID: 6404636
[TBL] [Abstract][Full Text] [Related]
20. Do gastric contents modify antidotal efficacy of oral activated charcoal?
Olkkola KT; Neuvonen PJ
Br J Clin Pharmacol; 1984 Nov; 18(5):663-9. PubMed ID: 6508975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
